UW Research

UW Positive Research

https://www.uwpositiveresearch.com

Mission

UW Positive Research aims to conduct rigorous human-centered research with the overarching goal of advancing science in order to improve medical care for people with HIV. Our research efforts are directed by cutting-edge science and guided by local and global Community Advisory Board input. Our intention is to conduct rigorous investigations predominantly focused on HIV treatment, HIV remission/cure, and comorbidities and co-infections associated with HIV. We will achieve our goals by partnering with patients and providers throughout the University of Washington, along with other collaborating institutions and community-based organizations, placing an emphasis on the participation of marginalized communities such as gender-diverse and BIPOC populations in our work at all levels.

Specific areas of research focus include:

  • Optimizing antiretroviral therapy (ART) strategies to improve ease of use and reduce side effects
  • Improving immune responses to HIV, including HIV remission strategies and work along the pathway to HIV cure
  • Treating and preventing co-infections, including hepatitis viruses, CMV, tuberculosis, and COVID-19
  • Addressing the complexities of aging with HIV, including the metabolic complications of HIV and ART, as well as neurocognitive changes
  • Developing treatment for HIV-associated cancers, including immunotherapy
  • Investigating treatment strategies for other conditions impacting people with HIV, including treatments for substance use disorders

Funding Information

National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) 2007-2027
Individual studies supported by the National Institute of Drug Abuse (NIDA), the Cancer Immunotherapy Trials Network (CITN and NCI), and partners in industry

Reporting Structure

Anna Wald, Head, Division of Allergy and Infectious Diseases

Related UW Entities

School of Medicine: Department of Laboratory Medicine, Department of Medicine, Department of Neurology
School of Pharmacy
UW/Fred Hutch Center for AIDS Research
Seattle Clinical Trials Unit